**Core Concept**
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the accumulation of malignant lymphocytes in the bone marrow and peripheral blood. The prognosis of CLL patients is influenced by several factors, including the presence of specific genetic mutations, the number of lymphocytes, and the presence of co-existing medical conditions.

**Why the Correct Answer is Right**
Patients with CLL who have deletion of the short arm of chromosome 17 (17p-) have a poor prognosis due to the presence of TP53 mutations. The TP53 gene acts as a tumor suppressor, and its inactivation leads to uncontrolled cell growth and resistance to chemotherapy. This deletion is associated with a higher risk of transformation to a more aggressive form of CLL, such as Richter's syndrome, and a shorter overall survival. The presence of 17p- is a significant adverse prognostic factor and is often used to guide treatment decisions.

**Why Each Wrong Option is Incorrect**
**Option A:** deletion of the long arm of chromosome 13 (13q-) is associated with a poor prognosis in CLL, but it is not as severe as deletion of 17p-.
**Option B:** trisomy 12 is a common genetic abnormality in CLL, but it is not associated with a poor prognosis.
**Option C:** normal karyotype is often seen in CLL patients with a good prognosis, but it does not necessarily indicate a favorable outcome.

**Clinical Pearl / High-Yield Fact**
Patients with CLL and deletion of 17p- often require more aggressive treatment approaches, including targeted therapies such as ibrutinib or venetoclax, and may benefit from participation in clinical trials.

**Correct Answer: D. deletion of the short arm of chromosome 17 (17p-).**